-
-
-
-
-
-
-
Ginkgo Bioworks Reports Second Quarter 2025 Financial Results
-
-
-
-
-
-
-
Ginkgo Regains Compliance with NYSE Minimum Bid Price Requirement
-
-
-
-
-
-
-
Ginkgo Bioworks (DNA) and Novo Nordisk (NVO) Expand Alliance to Collaborate Across R&D Value Chain
-
-
-
-
-
-
-
Ginkgo Bioworks Reports Fourth Quarter and Full Year 2023 Financial Results
-
-
-
-
-
-
-
Ginkgo Bioworks Acquires Reverie Labs Platform, Enhancing AI-Driven Drug Discovery Capabilities for Customer Programs
-
-
-
-
-
-
-
Bioluminescent Plants Are Now Even Brighter: Light Bio to Begin Selling Firefly Petunias to Consumers with USDA Approval
-
-
-
-
-
-
-
OneOne Biosciences Partners with Ginkgo Bioworks to Advance its Platform and Nitrogen Fixation Microbial Product
-
1,156,037 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

